ALPS Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$461K Buy
6,283
+76
+1% +$5.58K ﹤0.01% 660
2025
Q1
$709K Sell
6,207
-3,071
-33% -$351K ﹤0.01% 546
2024
Q4
$468K Sell
9,278
-79,711
-90% -$4.02M ﹤0.01% 625
2024
Q3
$4.12M Sell
88,989
-6,777
-7% -$314K 0.03% 253
2024
Q2
$3.11M Buy
95,766
+8,122
+9% +$264K 0.02% 280
2024
Q1
$2.21M Buy
87,644
+15,284
+21% +$385K 0.02% 333
2023
Q4
$2.35M Sell
72,360
-3,345
-4% -$109K 0.02% 311
2023
Q3
$2.06M Buy
75,705
+1,041
+1% +$28.4K 0.02% 318
2023
Q2
$1.66M Buy
74,664
+3,576
+5% +$79.6K 0.01% 346
2023
Q1
$1.54M Sell
71,088
-1,886
-3% -$40.9K 0.01% 356
2022
Q4
$1.48M Buy
+72,974
New +$1.48M 0.01% 360
2022
Q3
Sell
-14,486
Closed -$344K 1090
2022
Q2
$344K Sell
14,486
-149
-1% -$3.54K ﹤0.01% 705
2022
Q1
$330K Buy
+14,635
New +$330K ﹤0.01% 721
2021
Q1
Sell
-14,659
Closed -$383K 886
2020
Q4
$383K Sell
14,659
-299
-2% -$7.81K ﹤0.01% 559
2020
Q3
$260K Buy
+14,958
New +$260K ﹤0.01% 709
2020
Q1
Sell
-25,433
Closed -$308K 816
2019
Q4
$308K Sell
25,433
-1,127
-4% -$13.6K ﹤0.01% 795
2019
Q3
$375K Sell
26,560
-4,037
-13% -$57K ﹤0.01% 526
2019
Q2
$341K Sell
30,597
-1,614
-5% -$18K ﹤0.01% 808
2019
Q1
$378K Sell
32,211
-230
-0.7% -$2.7K ﹤0.01% 809
2018
Q4
$433K Sell
32,441
-1,308
-4% -$17.5K ﹤0.01% 534
2018
Q3
$473K Buy
33,749
+8,139
+32% +$114K ﹤0.01% 742
2018
Q2
$403K Sell
25,610
-1,204
-4% -$18.9K ﹤0.01% 765
2018
Q1
$441K Buy
26,814
+602
+2% +$9.9K ﹤0.01% 748
2017
Q4
$473K Hold
26,212
﹤0.01% 602
2017
Q3
$506K Buy
+26,212
New +$506K ﹤0.01% 490